Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Devgen delisted from NYSE Euronext Brussels

Belgian biotechnology company Devgen has been delisted from the NYSE Euronext Brussels exchange. The move is part of Syngenta’s acquisition bid for Devgen, which began in September last year ( Agrow No 653, p 2). Following the acquisition of 98.3% of shares in January, Syngenta opened a squeeze-out that closed on February 26th. The results of the squeeze-out will be announced on March 5th and payment of the shares and warrants tendered during the squeeze-out will take place on March 8th. Syngenta will hold 100% of the Devgen shares upon the closing and settlement of the squeeze-out.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG007281

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel